XIPERE

TRIAMCINOLONE ACETONIDE · Bausch & Lomb Incorporated

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for XIPERE, covering 2021-10-22 to 2025-05-22. Get the full timeline:

Most recent: FDA Approved: XIPERE — Supplemental Application (Bausch & Lomb Incorporated)